You are here

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Berlin, , 10117 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Obstructive Pulmonary Disease, Lung Diseases, Respiratory Tract Diseases, Chronic Obstructive Airway Disease, COPD
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
40-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female (women of non-childbearing potential) subjects between the ages of 40
and 80 years, inclusive with a diagnosis of moderate COPD (GOLD, 2007 update) and who
meet the following criteria for GOLD stage II disease

- Body Mass Index (BMI) of less than 35.5 kg/m2; and a total body weight >40 kg (88
lbs).

- Current smokers, or ex-smokers who have abstained from smoking for at least 6 months

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects having more than 2 exacerbations requiring treatment with oral steroids or
hospitalization for the treatment of COPD in the previous year.

- History of lower respiratory tract infection or significant disease instability during
the month preceding screening or during the period between screening and
randomization.

NCT01033487
Pfizer
Completed
A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Chronic Obstructive Pulmonary Disease
NCT00430300
All Genders
40+
Years
Multiple Sites
Asthma, Chronic Obstructive Pulmonary Disease
NCT01033669
All Genders
18+
Years
Berlin,
Chronic Obstructive Pulmonary Disease
NCT00472264
All Genders
40+
Years
St. Louis, Missouri
Chronic Obstructive Pulmonary Disease
NCT00219622
All Genders
40+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now